METHSCOPOLAMINE

SynDRA canonical compound SYN0006651 — structure-anchored drug synonym record

Clinical phase	Launched
Approval status	Approved · Rx/OTC
Primary target(s)	CHRM3
Mechanism of action	Acetylcholine receptor antagonist
Indication	peptic ulcer disease (PUD)
Disease area	gastroenterology

All known targets

methylscopolamine
N-Methylhyoscine
N-Methylscopolamine
methscopolamine bromide
methscopolamine nitrate
methylscopolamine bromide
Methylscopolamine
(-)-n-methylscopolamine
Methscopolamine cation
Methscopolamine ion
N-methylhyoscine
N-methylscopolamine
Methscopolamine Bromide
Pamine Forte
N-methyl scopolamine
UNII-VDR09VTQ8U
VDR09VTQ8U
CHEMBL376897
(1r,2r,4s,5s)-7-{[(2s)-3-hydroxy-2-phenylpropanoyl]oxy}-9,9-dimethyl-3-oxa-9-azoniatricyclo[33102,4]nonane
Metylskopolamin
3-Oxa-9-azoniatricyclo[33102,4]nonane, 7-[(2S)-3-hydroxy-1-oxo-2-phenylpropoxy]-9,9-dimethyl-, (1a,2b,4b,5a,7b)
HSDB 5420
[3H]N-methylscopolamine
[3H]N-methyl scopolamine
[3H]NMS
Methyl scopolamine
3C0
CHEMBL3140030
Pamine
[(1S,2S,4R,5R)-9,9-dimethyl-3-oxa-9-azoniatricyclo[3.3.1.02,4]nonan-7-yl] (2S)-3-hydroxy-2-phenylpropanoate
Methscopolamine (bromide)
3-Oxa-9-azoniatricyclo[3.3.1.02,4]nonane, 7-[(2S)-3-hydroxy-1-oxo-2-phenylpropoxy]-9,9-dimethyl-, (1a,2b,4b,5a,7b)
(1R,2R,4S,5S)-7-{[(2S)-3-hydroxy-2-phenylpropanoyl]oxy}-9,9-dimethyl-3-oxa-9-azatricyclo[3.3.1.0^{2,4}]nonan-9-ium
N-methylscopolamine (NMS)
SCHEMBL65398
GTPL316
GTPL317